Retrospective Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Aug 7, 2017; 23(29): 5379-5385
Published online Aug 7, 2017. doi: 10.3748/wjg.v23.i29.5379
Figure 1
Figure 1 Comparison of decreased body weight (%) between patients with and without hepatocellular carcinoma. The diuretic effect of tolvaptan was significantly higher in patients without hepatocellular carcinoma. HCC: Hepatocellular carcinoma.